Built on talent, technology, and trust, Grace is a leading global supplier of specialty chemicals within the Standard Industries family of companies. Our two industry-leading business segments—Catalysts Technologies and Materials Technologies—provide innovative products, technologies, and services that enhance the products and processes of our customers around the world. Through customer-driven innovation, strategic acquisitions, flexible worldwide manufacturing, and the talent of our people, we maintain strong strategic positions and unmatched customer relationships with many of the world’s best companies. Over 80 percent of our sales were in segments where we are #1 or #2. Grace, a Standard Industries company, is committed to delivering value, safely and sustainably, to customers, to shareholders, and to the communities in which we operate.

Centrus Energy is a trusted supplier of nuclear fuel and services for the nuclear power industry. Centrus provides value to its utility customers through the reliability and diversity of its supply sources – helping them meet the growing need for clean, affordable, carbon-free electricity. Since 1998, the Company has provided its utility customers with more than 1,750 reactor years of fuel, which is equivalent to 7 billion tons of coal. With world-class technical and engineering capabilities, Centrus is also advancing the next generation of centrifuge technologies so that America can restore its domestic uranium enrichment capability in the future. Find out more at www.centrusenergy.com.

At Emergent, we develop, manufacture, and deliver protections against public health threats. For more than two decades, we’ve been at work defending people from things we hope will never happen — so that we’re prepared, just in case they ever do. Please note: It has come to our attention that there may be people posing as Emergent recruiters and hiring managers online, offering fraudulent opportunities to job seekers. Emergent will never ask for any financial commitment from a candidate as a pre-employment requirement. Learn more about recruitment fraud and how to protect yourself here: https://bit.ly/recruitment-fraud

INEOS Pigments is one of the largest producers of titanium dioxide in North America and the leading producer of titanium chemicals.

For over 30 years, Miltenyi Biotec has been a major provider of products and services that drive biomedical research and boost cell and gene therapy. More than 4,700 employees in 23 countries combine excellence in research with innovative products to create cutting-edge solutions that make cancer and other disease history. Our expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. At Miltenyi Biotec, scientists, engineers, software developers and many other professionals work together to improve human health by providing smarter cellular technology solutions to researchers and clinicians worldwide.

We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States. We market Qelbree® (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in children ages 6 to 17. Trokendi XR® (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, Oxtellar XR® (extended-release oxcarbazepine) for the treatment of epilepsy, Apokyn® (apomorphine hydrochloride injection) for the acute treatment of hypomobility in advanced Parkinson’s disease (PD), Myobloc® (rimabotulinumtoxinB) for the treatment of cervical dystonia and treatment of chronic sialorrhea in adults, and Xadago® (safinamide) as an adjunctive treatment to levodopa/carbidopa in PD patients with hypomobility. We are also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD in adults, apomorphine infusion pump for hypomobility in PD, SPN-820 (NV-5138) for treatment-resistant depression, and SPN-817 for the treatment of epilepsy.

Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s first facility, Calcasieu Pass, commenced producing LNG in January 2022. The company is also constructing or developing an additional 60 MTPA of production capacity in Louisiana to provide clean, affordable energy to the world. The company is developing Carbon Capture and Sequestration (CCS) projects at each of its LNG facilities. For more information, visit https://www.venturegloballng.com

Built on talent, technology, and trust, Grace is a leading global supplier of specialty chemicals within the Standard Industries family of companies. Our two industry-leading business segments—Catalysts Technologies and Materials Technologies—provide innovative products, technologies, and services that enhance the products and processes of our customers around the world. Through customer-driven innovation, strategic acquisitions, flexible worldwide manufacturing, and the talent of our people, we maintain strong strategic positions and unmatched customer relationships with many of the world’s best companies. Over 80 percent of our sales were in segments where we are #1 or #2. Grace, a Standard Industries company, is committed to delivering value, safely and sustainably, to customers, to shareholders, and to the communities in which we operate.

USALCO is the premier manufacturer of various aluminum-based chemicals, such as aluminum sulfate, sodium aluminate, polyaluminum chloride, aluminum chlorohydrate, and aluminum chloride, to industrial and municipal markets. USALCO’s Polyaluminum Chloride (PACL) products, DelPAC® and UltraPAC®, have become the coagulants of choice in well over 1,000 water treatment applications throughout the US. USALCO’s research and development staff is committed to continuously innovating new coagulant chemistry to address the ever-changing regulatory landscape. Coupled with our on-site application expertise, USALCO is uniquely positioned to meet the increasing customer demand for improved treatment results at a lower total cost. Our company headquarters is in Baltimore, Maryland which is also the site of the largest aluminum coagulant manufacturing plant in North America. USALCO operates at 31 facilities throughout the United States.

McCormick & Company, Incorporated (NYSE: MKC) is a global leader in flavor and one of the most respected and familiar names in the industry. In business for over 130 years, McCormick manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the entire food industry—retail outlets, food manufacturers, and foodservice businesses. McCormick creates flavors for a wide range of applications, such as beverages, snacks, dairy, bakery/confectionary, savory, performance nutrition, and health. The McCormick name represents a trusted source of flavor in millions of kitchens around the globe—in homes and in restaurants. Partnerships with farmers and suppliers around the world allow us to provide great-tasting, quality spices with year-over-year consistency that you can trust. Our herbs and spices come from 80 different countries, while our brands reach consumers in more than 170 countries and territories. Our passion for quality is matched only by our commitment to an innovative and energetic company culture. At McCormick, we believe in respect, recognition, inclusion, and collaboration, based on the highest ethical values for our employees. McCormick is a team of approximately 14,000 employees located around the world—and we’re growing. If you have a passion for flavor—and you’re ready to take a journey—come have a seat at our table.

OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome-wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research. OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 30,000 human full-length TrueClone cDNA collections and over 25,000 TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the largest offering of full-length human proteins expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB project to develop mouse monoclonal antibodies against protein antigens to develop protein assays for every human protein. In addition, OriGene offers unique gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation OriGene is committed to its mission to be “Your Gene Company”, supplying everything a researcher needs for gene-based research. Visit us at https://www.origene.com